🇺🇸 FDA
Pipeline program

LENALIDOMIDE, LENALIDOMIDE, DEXAMETHASONE, LENALIDOMIDE, DEXAMETHASONE, LENALIDOMIDE, LENALIDOMIDE

EAE128

Phase 2 small_molecule active

Quick answer

LENALIDOMIDE, LENALIDOMIDE, DEXAMETHASONE, LENALIDOMIDE, DEXAMETHASONE, LENALIDOMIDE, LENALIDOMIDE for Newly diagnosed patients with multiple myeloma is a Phase 2 program (small_molecule) at Ology Bioservices Ireland LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
Ology Bioservices Ireland LTD
Indication
Newly diagnosed patients with multiple myeloma
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials